BioSpace News Archive

Policy

Alimera Sciences Receives Acceptance of Filing to Obtain Approval for ILUVIEN Non-Infectious Posterior Uveitis Indication in Europe

Alimera submitted the results from two, randomized, double-masked, multi-center phase 3 clinical trials.

January 4, 2018
·
6 min read
Business

Spero Therapeutics Appoints David Melnick, M.D., as Chief Medical Officer

Dr. Melnick to lead clinical team as Spero prepares to enter late-stage clinical trials.

January 4, 2018
·
4 min read
Oculis Raises CHF20 Million in a Series B Financing Round to Advance Breakthrough Treatments for Ophthalmic Diseases

The financing was led by a syndicate of leading international life science investors including Bay City Capital, Novartis Venture Fund and Pivotal bioVenture Partners.

January 4, 2018
·
3 min read
Drug Development

Spitfire Pharma’s SP-1373 Outscored Semaglutide and Elafibranor in a Biopsy-Proven Translational Mouse Model of Non-Alcoholic Steatohepatitis (NASH)

Spitfire Pharma announced today that SP-1373, its lead glucagon-like peptide-1 and glucagon receptor dual agonist compound, demonstrated superior outcome measures in liver histopathology and metabolic parameters versus semaglutide and elafibranor in the biopsy-proven, AMLN-diet Gubra NASH mouse model.

January 4, 2018
·
4 min read
Genetown

Enterome Raises €32M ($38.5M) in a Series D Financing

The proceeds of the fundraising will be used primarily to progress two proof-of concept clinical trials of Enterome’s lead development programs.

January 4, 2018
·
8 min read
Business

Nephros Announces Preliminary Financial Results for Fourth Quarter 2017

Nephros expects product revenue for the fourth quarter ended December 31, 2017, to be approximately $1,258,000, an increase of approximately 83% over the same period in 2016.

January 4, 2018
·
3 min read
Business

Spark Therapeutics Announces Addition of Robert J. Perez to Board of Directors

Mr. Perez has been the founder and managing partner of Vineyard Sound Advisors since 2015.

January 4, 2018
·
2 min read
Business

PellePharm Appoints Sanuj K. Ravindran, M.D., as President and CEO

Dr. Ravindran brings more than 15 years of strategic and operational biopharma experience to PellePharm.

January 4, 2018
·
5 min read
Median Technologies Ranks in Deloitte Technology Fast 500 EMEA for 2017

Median grew by 428% over the period with increasing demand of the company’s medical imaging contract research services or iCRO.

January 4, 2018
·
4 min read
Policy

TearLab Submits 510(k) for U.S. FDA Clearance of TearLab Discovery Platform

TearLab Discovery will also be capable of performing the Company’s current FDA cleared tear osmolarity test.

January 4, 2018
·
4 min read